DA
ZBH icon

DCF Advisers’s Zimmer Biomet ZBH Stock Holding History

DCF Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,000
Closed -$217K – 108
2024
Q2 		$217K Buy
+2,000
New +$236K 0.11% 85

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCF Advisers's ZBH Position: Q1 2026 in Review

DCF Advisers held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 30,500 shares worth $2.76M. The position accounts for 0.74% of the portfolio, ranked #32.

DCF Advisers first reported a position in ZBH in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.03M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • DCF Advisers held 30,500 shares of Zimmer Biomet worth $2.76M as of Q1 2026.
  • DCF Advisers left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up 0.74% of DCF Advisers's portfolio in Q1 2026, its #32 holding.
  • DCF Advisers first reported a position in Zimmer Biomet in Q2 2023 and has held it in 12 quarters since.
  • DCF Advisers's Zimmer Biomet position peaked at $3.03M in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.